Compare VTSI & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTSI | EVAX |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.5M | 42.7M |
| IPO Year | N/A | 2021 |
| Metric | VTSI | EVAX |
|---|---|---|
| Price | $4.97 | $4.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $12.33 |
| AVG Volume (30 Days) | 61.1K | ★ 65.9K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $24,934,267.00 | $7,650,000.00 |
| Revenue This Year | N/A | $128.77 |
| Revenue Next Year | $13.39 | N/A |
| P/E Ratio | $346.40 | ★ N/A |
| Revenue Growth | N/A | ★ 132.17 |
| 52 Week Low | $3.57 | $1.20 |
| 52 Week High | $7.47 | $12.15 |
| Indicator | VTSI | EVAX |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 33.45 |
| Support Level | $4.54 | $4.11 |
| Resistance Level | $5.07 | $4.85 |
| Average True Range (ATR) | 0.25 | 0.38 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 77.75 | 8.23 |
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.